{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:11:00Z","timestamp":1761743460213},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,1]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Stability and transport challenges make hemoglobin (Hb) A1c measurement from EDTA whole blood (WB) inconvenient and costly for large-scale population studies. This study investigated Hb A1c measurement from WB blotted on filter paper (FP) in a Level I National Glycohemoglobin Standardization Program (NGSP)-accredited laboratory.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Three Bio-Rad Variant\u2122 II HPLC instruments and WB and FP specimens were used. Precision, accuracy, linearity, and readable total area of the 6.5-min (\u03b2-thalassemia method) Variant II HbA2\/HbA1c Dual Program were assessed. Hb A1c stability was measured using in-house FP QC samples. The INTERHEART (a study of the effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries) and CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Events) studies provided chromatographs for morphometric analyses and interoperator variability experiments. Statistical analyses were performed to assess long-term sample stability, WB vs FP agreement, and significance of Hb A1c peak integration.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Intra- and interassay CVs were \u22642.00%. Total area counts between 0.8 and 5.5 \u00d7 106 \u03bcV\/s produced accurate Hb A1c results. The regression equation for agreement between WB(x) and FP(y) was as follows: y = 0.933x + 0.4 (n = 85). FP QC samples stored at \u221270 \u00b0C and tested over approximately 3 years yielded CVs of 1.72%\u20132.73% and regression equations with slopes of \u22121.08 \u00d7 10\u22124 to 7.81 \u00d7 10\u22124. The CURE study, with better preanalytical preparation, achieved a 97% reportable rate, and the reportable rate of the INTERHEART study was 85%.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The FP collection method described provided accurate, robust, and reproducible measurement of Hb A1c using the Bio-Rad Variant II HPLC autoanalyzer when FP specimens were prepared according to standardized protocols, and analyses were performed in an NGSP-certified laboratory, supporting the use of FP collection cards in large multinational studies.<\/jats:p><\/jats:sec>","DOI":"10.1373\/clinchem.2010.156380","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T04:31:51Z","timestamp":1296880311000},"page":"577-585","source":"Crossref","is-referenced-by-count":22,"title":["Measurement of Hemoglobin A1c from Filter Papers for Population-Based Studies"],"prefix":"10.1093","volume":"57","author":[{"given":"David A","family":"Egier","sequence":"first","affiliation":[{"name":"Clinical Research and Clinical Trials Laboratory (CRCTL), Hamilton General Hospital, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy L","family":"Keys","sequence":"first","affiliation":[{"name":"Clinical Research and Clinical Trials Laboratory (CRCTL), Hamilton General Hospital, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Kim","family":"Hall","sequence":"first","affiliation":[{"name":"Clinical Research and Clinical Trials Laboratory (CRCTL), Hamilton General Hospital, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J","family":"McQueen","sequence":"first","affiliation":[{"name":"Clinical Research and Clinical Trials Laboratory (CRCTL), Hamilton General Hospital, Hamilton, Ontario, Canada"},{"name":"Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada"},{"name":"Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"2020022704531291900_B1","article-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2009","edition":"4th ed."},{"key":"2020022704531291900_B2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates, and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"2020022704531291900_B3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2020022704531291900_B4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy","volume":"342","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2000","journal-title":"N Engl J Med"},{"key":"2020022704531291900_B5","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.2337\/db06-0653","article-title":"The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"55","author":"Cleary","year":"2006","journal-title":"Diabetes"},{"key":"2020022704531291900_B6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/clinchem\/47.7.1157","article-title":"Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus","volume":"47","author":"Krishnamurti","year":"2001","journal-title":"Clin Chem"},{"key":"2020022704531291900_B7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/diacare.23.2.187","article-title":"Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population","volume":"23","author":"Rohlfing","year":"2000","journal-title":"Diabetes Care"},{"key":"2020022704531291900_B8","first-page":"1522","article-title":"Glycated hemoglobin","volume":"83","author":"Chandalia","year":"2002","journal-title":"Curr Sci"},{"key":"2020022704531291900_B9","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/clinchem\/43.10.1811","article-title":"Another step toward standardization of methods for measuring hemoglobin A1c","volume":"43","author":"Eckfeldt","year":"1997","journal-title":"Clin Chem"},{"key":"2020022704531291900_B10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198402093100602","article-title":"The clinical information value of the glycosylated hemoglobin assay","volume":"310","author":"Nathan","year":"1984","journal-title":"N Engl J Med"},{"key":"2020022704531291900_B11","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00125-007-0803-0","article-title":"Relationship between glycated haemoglobin levels and mean glucose levels over time","volume":"50","author":"Nathan","year":"2007","journal-title":"Diabetologia"},{"key":"2020022704531291900_B12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1172\/JCI108534","article-title":"Red cell age-related changes of hemoglobins A1a+b and A1c in normal and diabetic patients","volume":"58","author":"Fitzgibbons","year":"1976","journal-title":"J Clin Invest"},{"key":"2020022704531291900_B13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2337\/diacare.16.9.1313","article-title":"The response of GHb to stepwise plasma glucose change over time in diabetic patients","volume":"16","author":"Tahara","year":"1993","journal-title":"Diabetes Care"},{"key":"2020022704531291900_B14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/dia.2006.0055","article-title":"Effects of sample storage conditions on glycated hemoglobin measurement: evaluation of five different high performance liquid chromatography methods","volume":"9","author":"Little","year":"2007","journal-title":"Diabetes Technol Ther"},{"key":"2020022704531291900_B15","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1464-5491.2005.01705.x","article-title":"Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade","volume":"22","author":"Selvin","year":"2005","journal-title":"Diabet Med"},{"key":"2020022704531291900_B16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8227(98)00046-1","article-title":"Immediate assessment of HbA1c under field conditions in Tanzania","volume":"40","author":"Wikblad","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"key":"2020022704531291900_B17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2337\/diacare.19.2.142","article-title":"Capillary blood on filter paper for determination of HbA1c by ion exchange chromatography","volume":"19","author":"Jeppsson","year":"1996","journal-title":"Diabetes Care"},{"key":"2020022704531291900_B18","first-page":"115","article-title":"Accuracy of filter paper method for measuring glycated hemoglobin","volume":"55","author":"Anjali","year":"2007","journal-title":"J Assoc Physicians India"},{"key":"2020022704531291900_B19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/152091599316928","article-title":"Prospective evaluation of accuracy, precision, and reproducibility of an at-home hemoglobin A1c sampling kit","volume":"1","author":"Parkes","year":"1999","journal-title":"Diabetes Technol Ther"},{"key":"2020022704531291900_B20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1515\/CCLM.2009.274","article-title":"HbA1c measurements from dried blood spots: validation and patient satisfaction","volume":"47","author":"Fokkema","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"2020022704531291900_B21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"2020022704531291900_B22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.hjr.0000220582.19516.a6","article-title":"Renal function and outcomes in acute coronary syndrome: impact of clopidogrel","volume":"14","author":"Keltai","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2020022704531291900_B23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/clinchem\/48.3.436","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"48","author":"Sacks","year":"2002","journal-title":"Clin Chem"},{"key":"2020022704531291900_B24","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","article-title":"Tests of glycemia in diabetes","volume":"27","author":"Goldstein","year":"2004","journal-title":"Diabetes Care"},{"key":"2020022704531291900_B25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jcp.55.9.699","article-title":"Silent haemoglobin variants and determination of HbA1c with the HPLC Bio-Rad Variant II","volume":"55","author":"Lahousen","year":"2002","journal-title":"J Clin Pathol"},{"key":"2020022704531291900_B26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1373\/clinchem.2004.034991","article-title":"HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60,000 samples in a clinical diagnostic laboratory","volume":"50","author":"Joutovsky","year":"2004","journal-title":"Clin Chem"},{"key":"2020022704531291900_B27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clinbiochem.2004.11.004","article-title":"Tentative identification of hemoglobin variants in the Bio-Rad Variant II HbA1c method","volume":"38","author":"Higgins","year":"2005","journal-title":"Clin Biochem"},{"key":"2020022704531291900_B28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0009-9120(01)00229-6","article-title":"Analytical evaluation of the Bio-Rad Variant II automated HbA1C analyzer","volume":"34","author":"Higgins","year":"2001","journal-title":"Clin Biochem"},{"key":"2020022704531291900_B29","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.5858\/2002-126-1494-EOADHA","article-title":"Evaluation of a dual hemoglobin A2\/A1c quantitation kit on the Bio-Rad Variant II automated hemoglobin analyzer","volume":"126","author":"Lafferty","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"2020022704531291900_B30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0009-9120(03)00013-4","article-title":"Analytical evaluation of hemoglobin A1c dual kit assay on Bio-Rad Variant II: an automated HPLC hemoglobin analyzer for the management of diabetic patients","volume":"36","author":"Moridani","year":"2003","journal-title":"Clin Biochem"},{"key":"2020022704531291900_B31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/193229681000400203","article-title":"Analysis of hemoglobin A1c from dried blood spot samples with the Tina-quant II immunoturbidimetric method","volume":"4","author":"Jones","year":"2010","journal-title":"J Diabetes Sci Technol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/57\/4\/577\/32655107\/clinchem0577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/57\/4\/577\/32655107\/clinchem0577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T15:30:02Z","timestamp":1637249402000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/57\/4\/577\/5621039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,1]]},"published-print":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2010.156380","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,4,1]]},"published":{"date-parts":[[2011,4,1]]}}}